{{Rsnum
|rsid=225675
|Gene=VTA1
|Chromosome=6
|position=142190999
|Orientation=plus
|GMAF=0.2952
|Gene_s=VTA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 18.5 | 52.3 | 29.2
| HCB | 71.1 | 26.7 | 2.2
| JPT | 70.5 | 29.5 | 0.0
| YRI | 71.4 | 25.4 | 3.2
| ASW | 0.0 | 0.0 | 0.0
| CHB | 71.1 | 26.7 | 2.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=G
  |Pval=1E-7
  |OR=5.29
  |ORtxt=[3.35-7.23] mg/dL decrease
  |OA=1
}}